Canada Life’s IGM Biosciences IGMS Stock Holding History

Canada Life’s Portfolio IGMS Stock Details IGMS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-569	Closed	-$5K	–	2190
2023 Q3	$5K	Hold	569	–	–	﹤0.01%	2227
2023 Q2	$5K	Hold	569	–	–	﹤0.01%	2254
2023 Q1	$8K	Hold	569	–	–	﹤0.01%	2302
2022 Q4	$10K	Hold	569	–	–	﹤0.01%	2321
2022 Q3	$13K	Hold	569	–	–	﹤0.01%	2310
2022 Q2	$10K	Hold	569	–	–	﹤0.01%	2358
2022 Q1	$16K	Hold	569	–	–	﹤0.01%	2387
2021 Q4	$17K	Hold	569	–	–	﹤0.01%	2406
2021 Q3	$38K	Hold	569	–	–	﹤0.01%	2300
2021 Q2	$47K	Hold	569	–	–	﹤0.01%	2290
2021 Q1	$43K	Hold	569	–	–	﹤0.01%	2335
2020 Q4	$50K	Hold	569	–	–	﹤0.01%	2279
2020 Q3	$42K	Hold	569	–	–	﹤0.01%	2221
2020 Q2	$41K	Buy	+569	New	+$34.6K	﹤0.01%	2281

Other funds holding IGMS

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return

Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Canada Life's IGMS Position: Q4 2023 in Review

Canada Life sold out of IGM Biosciences (IGMS) in Q4 2023, closing a stake of 569 shares — an estimated $5K sold.

Canada Life first reported a position in IGMS in Q2 2020 and held it in 14 quarters. The position peaked at $50K in Q4 2020. 72 funds tracked by Wall St. Rank hold IGMS as of Q4 2023.

Canada Life reported no remaining IGM Biosciences position as of Q4 2023 after selling out during the quarter.
Canada Life sold 569 IGM Biosciences shares in Q4 2023, an estimated $5K.
Canada Life first reported a position in IGM Biosciences in Q2 2020 and held it in 14 quarters.
Canada Life's IGM Biosciences position peaked at $50K in Q4 2020.
72 funds tracked by Wall St. Rank held IGM Biosciences as of Q4 2023.

Based on Canada Life's 13F filing for Q4 2023, filed 13 Feb 2024.